Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London open: FTSE nudges down ahead of Fed, US tech earnings
(Sharecast News) - London stocks nudged lower in early trade on Wednesday as investors eyed the latest policy announcement from the Federal Reserve and earnings from three of the 'Magnificent Seven'. At 0855 GMT, the FTSE 100 was down 0.1% at 10,195.62.
Emma Wall, chief investment strategist at Hargreaves Lansdown, said: "It's a big day for Big Tech as the market awaits earnings from Meta, Microsoft and Tesla later today - and Apple reporting tomorrow.
"These are the companies which can move not just their own share price but that of the whole market, and in particular the eagle eared will be listening to Elon Musk's commentary on the earnings call where more detail is often provided on financial forecasts and long-term strategy for the business."
As far as the Fed is concerned, expectations are for interest rates to remain at 3.5% to 3.75%. Wall said Chair Jerome Powell's statement may trigger volatility.
"Powell has been vocal in recent weeks about the President's plot to oust him and some market twitchers expect further comment today - potentially even regarding Powell's intentions to stay on the Committee after his term as Chair ends this year.
"Technically he can stay on the Committee until January 2028, which the market will interpret as higher for longer, for even longer, interest rates."
In equity markets, the likes of GSK and AstraZeneca, which derive a significant chunk of their earnings in US dollars, were hit by weakness in the US currency.
Meanwhile, precious metals miner Fresnillo and gold miners Endeavour and Hochschild all shone as gold prices kept rising amid the plunging dollar.
Susannah Streeter, chief investment strategist at Wealth Club, said: "The dollar has shot off on another slippery slide, as Trump's spin on the currency's decline sparked another drop in confidence. The dollar's drop is giving extra shine to gold, which is on a seemingly unstoppable run upwards.
"The pound is now at levels not seen since September 2021, touching $1.37 before falling back slightly. The sharp moves in currencies, with sterling strengthening are acting as a dampener on the FTSE 100. It puts pressure on the overseas earnings of listed multinationals, with pharma giants GSK and Astra Zeneca, chemicals company Croda, and fashion house Burberry among the fallers in early trade."
Burberry was also knocked lower by disappointing results from French luxury group LVHM.
Pets at Home rallied after saying full-year underlying earnings were set to be in line with expectations despite a fall in third-quarter revenues.
British Land edged lower after agreeing to buy Life Science Reit as it looks to ramp up its presence in the fast-growing science and technology sector. The deal values Life Science Reit, which last autumn said it would pursue a managed wind down, at £150m, a premium of around 21%.
Life Science Reit, whose shares shot up nearly 20% on the news, said it now believed a sale would provide a "superior outcome" for shareholders.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.